Human amniotic-derived mesenchymal stem cells
HOPE-CAMSC
Phase 1 mab active
Quick answer
Human amniotic-derived mesenchymal stem cells for Chronic Kidney Diseases is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Chronic Kidney Diseases
- Phase
- Phase 1
- Modality
- mab
- Status
- active